...
Doses | Series Name | Absolute Minimum Interval | Minimum Interval | Recommended Interval | Latest Recommended Interval (less than) |
---|---|---|---|---|---|
Dose 1 to 2 | Pfizer COVID-19 Series | 8 weeks - 4 days if dose 2 administered >= 4/19/2023 and dose 1 administered >= 5 years of age Otherwise, 17 days | 8 weeks if the execution date is >= 4/19/2023 and dose 1 was administered >= 5 years of age Otherwise, 21 days | 8 weeks if the execution date is >= 4/19/2023 and dose 1 was administered >= 5 years of age Otherwise, 21 days |
N/A |
Dose 2 to 3 | Pfizer COVID-19 Series | 8 weeks - 4 days | 8 weeks | 8 weeks | N/A |
...
Panel | ||||||||
---|---|---|---|---|---|---|---|---|
| ||||||||
Series Special Rules
Vaccine to Recommend
Skip Dose Rule
Rule for CVX 212 (Janssen COVID-19 vaccine)
|
...
Doses | Series Name | Absolute Minimum Interval | Minimum Interval | Minimum Recommended Interval | Latest Recommended Interval (less than) |
---|---|---|---|---|---|
Dose 1 to 2 | Mixed Product COVID-19 Series | 8 weeks - 4 days if dose 2 administered >= 4/19/2023 and dose 1 administered >= 5 years of age Otherwise:
| 8 weeks if the execution date is >= 4/19/2023 and dose 1 was administered >= 5 years of age Otherwise, 28 days | 8 weeks if the execution date is >= 4/19/2023 and dose 1 was administered >= 5 years of age Otherwise, 28 days | N/A |
Dose 2 to 3 | Mixed Product COVID-19 Series | 8 weeks - 4 days | 8 weeks | 8 weeks | N/A |
...